HomeBUSINESS
BUSINESS

Ono Out-Licenses New I/O Candidate to Bristol-Myers
(Dec.15.2017)

Ono Pharmaceutical said on December 14 that it has sealed an agreement with Bristol-Myers Squibb, granting the US partner the rights to develop and commercialize its immuno-oncology candidate ONO-4578 in global markets outside Japan and certain other Asian territories ...
(LOG IN FOR FULL STORY)

News Calendar